FDA approves Linzess to treat certain cases of irritable bowel syndrome and constipation
Tweet Send to a Friend
Below is the FDA press release related to approval of Ironwood Pharmaceuticals' (NASDAQ: IRWD) and Forest Labs' (NYSE: FRX) Linzess:
This article: 439 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 439 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
